AEGERA THERAPEUTICS
Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.
AEGERA THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1997-01-01
Address:
Montrรฉal, Quebec, Canada
Country:
Canada
Website Url:
http://www.aegera.com
Total Employee:
11+
Status:
Closed
Contact:
(514) 288-553
Total Funding:
35.63 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF LetsEncrypt Mobile Non Scaleable Content IPv6 Cloudflare Hosting Microsoft Exchange Online Office 365 Mail Cloudflare CDN
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2007-08-08 | LymphoSign | LymphoSign acquired by Aegera Therapeutics | N/A |
Investors List
Business Development Bank of Canada
Business Development Bank of Canada investment in Series C - Aegera Therapeutics
Desjardins Venture Capital
Desjardins Venture Capital investment in Series C - Aegera Therapeutics
Multiple Capital
Multiple Capital investment in Series C - Aegera Therapeutics
VenGrowth Asset Management
VenGrowth Asset Management investment in Series C - Aegera Therapeutics
GrowthWorks Capital
GrowthWorks Capital investment in Series C - Aegera Therapeutics
Canadian Medical Discoveries Fund
Canadian Medical Discoveries Fund investment in Venture Round - Aegera Therapeutics
Business Development Bank of Canada
Business Development Bank of Canada investment in Venture Round - Aegera Therapeutics
GeneChem
GeneChem investment in Venture Round - Aegera Therapeutics
Innovatech Grand Montreal
Innovatech Grand Montreal investment in Venture Round - Aegera Therapeutics
Official Site Inspections
http://www.aegera.com
- Host name: 104.21.86.104
- IP address: 104.21.86.104
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aegera Therapeutics"
Aegera Therapeutics - Company Profile - Tracxn
Aegera Therapeutics, part of Pharmascience, is focused on developing targeted therapeutics to address major unmet medical needs. Aegera focuses on preclinical and early-stage clinical โฆSee details»
Aegera Therapeutics Company Profile 2024: Valuation, Investors ...
Aegera Therapeutics General Information Description. Developer of targeted therapeutics to address major unmet medical needs. The company has various programs investigating on โฆSee details»
Aegera Therapeutics Inc. Information - RocketReach
Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical โฆSee details»
Aegera Therapeutics Inc. - LinkedIn
Aegera Therapeutics Inc. | 311 followers on LinkedIn. Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet โฆSee details»
Aegera Therapeutics Inc. Management Team | Org Chart
Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical โฆSee details»
Pharmascience Inc. Acquires Aegera Therapeutics; Aegera's โฆ
May 27, 2011 We are pleased to welcome Aegera's employees to our team, which will broaden and strengthen the development of our organization," concluded Pharmascience President & โฆSee details»
Aegera Therapeutics - Overview, News & Similar companies
Aegera Therapeutics is a well-funded, clinical-stage, Canadian biotechnology company focused on developing drugs that control apoptosis to address major, unmet medical needs. Aegera โฆSee details»
Aegera Therapeutics Inc. Financial Overview, Employee Count, and ...
Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its โฆSee details»
Aegera Therapeutics - Company info. interviews, news
Jul 28, 2021 Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based โฆSee details»
Aegera Therapeutics - Funding, Financials, Valuation & Investors
Aegera Therapeutics is funded by 8 investors. Business Development Bank of Canada and Desjardins Venture Capital are the most recent investors. Aegera Therapeutics has acquired โฆSee details»
Aegera Therapeutics Inc. - VentureRadar
Find out more about Aegera Therapeutics Inc. including the VentureRadar Innovation and Growth scores, Similar Companies and more. All; Ranked; Organisation Names; Apps and Links. โฆSee details»
Aegera Therapeutics - Contacts, Employees, Board Members
Organization. Aegera Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Highlights. Employee Profiles 2. Number of Board Member and โฆSee details»
Aegera Oncology Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Aegera Oncology of Ottawa, ON. Get the latest business insights from Dun & Bradstreet.See details»
Aegera Therapeutics (Canada) - Wikidata
Aegera Therapeutics (Canada) (Q30283518) From Wikidata. Jump to navigation Jump to search. company in Montreal, Canada. edit. Language Label Description Also known as; English: โฆSee details»
An (A) - AEgera Therapeutic Inc AEgera Company Details
Here are few links to the location (on the map) to AEgera Therapeutic Inc organization. Simply follow the links below to see the actual map. A) See Map On Google B) Check This Map on โฆSee details»
Aegera Therapeutics Closes CDN$7 Million Financing - Newswire
MONTREAL , Sept. 23 /CNW Telbec/ - Aegera Therapeutics, a clinical stage biotechnology company focussed on developing targeted therapeutics for oncology and pain, announced โฆSee details»
Pharmascience Acquires Aegera Therapeutics Inc. - Fierce Pharma
May 27, 2011 Aegera's 20 plus employees will retain their jobs and will join the Pharmascience team. About Pharmascience. Founded in 1983, Pharmascience is a Canadian-owned โฆSee details»
Aegera Raises C$17M In First Round To Fund Two Platforms
Mar 5, 2002 Aegera Therapeutics Inc. raised C$17 million (US$10.7 million) in a private round of financing, which it will use to move its XIAP antisense program into Phase I trials in cancer โฆSee details»
What is Aegera Therapeutics? Company Culture, Mission, Values
See what employees say it's like to work at Aegera Therapeutics. Salaries, reviews, and more - all posted by employees working at Aegera Therapeutics.See details»